Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soininen

Showing results (471-480 of 1,209) with videos related to

Pageof 121
Sort By:
Human Genetics|April 27, 2004
Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementiaJaana Autere, Jukka S Moilanen, Saara Finnilä, et al.
Journal of Sports Sciences|November 28, 2013
Cardiovascular fitness and haemodynamic responses to maximal cycle ergometer exercise test in children 6-8 years of ageNiina Lintu, Tuomo Tompuri, Anna Viitasalo, et al.
The Journal of Pediatrics|June 16, 2010
Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccinationMerja Väkeväinen, Anu Soininen, Marilla Lucero, et al.
Neuro-Degenerative Diseases|February 4, 2012
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairmentLennart Thurfjell, Jyrki Lötjönen, Roger Lundqvist, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2013
Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairmentSusanna L Lundström, Hongqian Yang, Yaroslav Lyutvinskiy, et al.
Journal of Neurology|October 20, 1999
Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individualsS Helisalmi, M Hiltunen, P Valonen, et al.
International Psychogeriatrics|November 26, 2019
Midlife improvements in financial situation are associated with a reduced dementia risk later in life: the CAIDE 30-year studyS Sindi, A Darin-Mattsson, I Kåreholt, et al.
Neuroscience|February 14, 1998
Tetrahydroaminoacridine improves the recency effect in Alzheimer's diseaseM Riekkinen, H Soininen, P Riekkinen, et al.
Neurology|November 23, 2000
MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish malesW F Reynolds, M Hiltunen, M Pirskanen, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
Pageof 121

Showing results (471-480 of 1,209) with videos related to

Sort By:
Pageof 121
Human Genetics|April 27, 2004
Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementiaJaana Autere, Jukka S Moilanen, Saara Finnilä, et al.
Journal of Sports Sciences|November 28, 2013
Cardiovascular fitness and haemodynamic responses to maximal cycle ergometer exercise test in children 6-8 years of ageNiina Lintu, Tuomo Tompuri, Anna Viitasalo, et al.
The Journal of Pediatrics|June 16, 2010
Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccinationMerja Väkeväinen, Anu Soininen, Marilla Lucero, et al.
Neuro-Degenerative Diseases|February 4, 2012
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairmentLennart Thurfjell, Jyrki Lötjönen, Roger Lundqvist, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2013
Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairmentSusanna L Lundström, Hongqian Yang, Yaroslav Lyutvinskiy, et al.
Journal of Neurology|October 20, 1999
Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individualsS Helisalmi, M Hiltunen, P Valonen, et al.
International Psychogeriatrics|November 26, 2019
Midlife improvements in financial situation are associated with a reduced dementia risk later in life: the CAIDE 30-year studyS Sindi, A Darin-Mattsson, I Kåreholt, et al.
Neuroscience|February 14, 1998
Tetrahydroaminoacridine improves the recency effect in Alzheimer's diseaseM Riekkinen, H Soininen, P Riekkinen, et al.
Neurology|November 23, 2000
MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish malesW F Reynolds, M Hiltunen, M Pirskanen, et al.
Current Medical Research and Opinion|November 9, 2007
Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapyParaskevi Sakka, Magda Tsolaki, Jakub Hort, et al.
Pageof 121